Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Urologia Internationalis

Volumn 96, Issue 2, 2016, Pages 202-206

  Bozkurt, Aliseydi ^a   Karabakan, Mehmet ^a   Keskin, Ercument ^a   Hirik, Erkan ^a   Can Balci, M B ^b   Nuhoglu, Baris ^a  

^a ERZINCAN UNIVERSITY   (Turkey)

^b ISTANBUL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Benign prostatic hyperplasia; Minimally invasive surgery; Prostatic urethral lift

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; INTRAOPERATIVE RADIOTHERAPY; LOWER URINARY TRACT SYMPTOM; MALE; MICTURITION; MINIMALLY INVASIVE PROCEDURE; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE URETHRA; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL FUNCTION; URETHRA SURGERY; UROFLOWMETRY; ADVERSE EFFECTS; COMPLICATION; CONVALESCENCE; DEVICES; EJACULATION; LOWER URINARY TRACT SYMPTOMS; MALE GENITAL SYSTEM SURGERY; PATHOPHYSIOLOGY; PENIS ERECTION; PROSTATIC HYPERPLASIA; PROSTHESIS DESIGN; QUALITY OF LIFE; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME; URETHRA; URODYNAMICS;

EJACULATION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; PENILE ERECTION; PROSTATIC HYPERPLASIA; PROSTHESIS DESIGN; QUALITY OF LIFE; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; URETHRA; URODYNAMICS; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 84959147838     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000441850     Document Type: Article

References (27)

1. Roehrborn CG: Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. Rev Urol 2008; 10: 14-25.
2. Nordling J: Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia. BJU Int 2005; 95: 1006-1012.
3. Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, et al: Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2011; 108: 82-88.
4. Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC: Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph Project. Eur Urol 2003; 44: 539-545.
5. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al: EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms incluDing benign prostatic obstruction. Eur Urol 2013; 64: 118-140.
6. Rassweiler J, Teber D, Kuntz R, Hofmann R: Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol 2006; 50: 969-980; discussion 980.
7. McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al: Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011; 185: 1793-1803.
8. Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S: UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol 2012; 19: 6217-6222.
9. McNicholas TA, Woo HH, Chin PT, Bolton D, Fernández Arjona M, Sievert KD, et al: Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol 2013; 64: 292-299.
10. Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al: Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology 2012; 79: 5-11.
11. National Institute for Health and Care Excellence (NICE): Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia, 2014.
12. National Institute for Health and Care Excellence (NICE): Interventional procedure overview of insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia: overview, 2014.
13. Perera M, Roberts MJ, Doi SA, Bolton D: Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol 2015; 67: 704-713.
14. Shore N, Freedman S, Gange S, Moseley W, Heron S, Tutrone R, et al: Prospective multicenter study elucidating patient experience after prostatic urethral lift. Can J Urol 2014; 21: 7094-7101.
15. McVary KT, Gange SN, Shore ND, Bolton DM, Cowan BE, Brown BT, et al: Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. J Sex Med 2014; 11: 279-287.
16. Garrido Abad P, Coloma Del Peso A, Sinues Ojas B, Fernández Arjona M: [Urolift , a new minimally invasive treatment for patients with low urinary tract symptoms secondary to BPH. Preliminary results]. Arch Esp Urol 2013; 66: 584-591.
17. Delongchamps NB, Conquy S, Defontaines J, Zerbib M, Peyromaure M: [Intra-prostatic UroLift ( ) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France]. Prog Urol 2012; 22: 590-597.
18. Ak?n Y, Bozkurt A, Keles MO, Gulmez H, Sahin M, Nuhoglu B: Benign Prostat Hiperplazisi'nin Yeni Minimal ?nvaziv Tedavi Secenegi: Prostat ?çerisine UroLift Uygulamas?, Erken Dönem Sonuçlar? ile Turkiye'den ilk Vaka Serisi. JAREM 2013; 3: 74-78.
19. Broggi E, May A, Giretti G, Tabchouri N, Lorphelin H, Brichart N, et al: Long-term outcomes of 80-watt KTP and 120-watt HPS GreenLight photoselective vaporization of the prostate. Urol Int 2014; 93: 229-236.
20. Bulut S, Ozden C, Aktas BK, Deren T, Tagci S, Gokkaya CS, et al: Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia. Urol Int 2015; 94: 181-186.
21. Lukacs B, Loeffler J, Bruyère F, Blanchet P, Gelet A, Coloby P, et al: Photo selective vaporization of the prostate with Green Light 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 2012; 61: 1165-1173.
22. Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al: The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT study. J Urol 2013; 190: 2161-2167.
23. Cantwell AL, Bogache WK, Richardson SF, et al: Multicentre prospective crossover study of the 'prostatic urethral lift' for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 2014; 113: 615-622.
24. Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, et al: Durability of the prostatic urethral lift: 2-year results of the LIFT study. Urol Pract 2015; 2: 26-32.
25. Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, et al: Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2012; 9:CD004135.
26. Frieben RW, Lin HC, Hinh PP, Berardinelli F, Canfield SE, Wang R: The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl 2010; 12: 500-508.
27. Hoffman RM, MacDonald R, Wilt TJ: Laser prostatectomy for benign prostatic obstruction. Cochrane Database Syst Rev 2004; 1: CD001987.